Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Publication

Article

September 14, 2011

CURE

Fall 2011
Volume10
Issue 3

Managing Cancer-Related Diarrhea

Author(s):

Katy Human

Cancer-related diarrhea can be cause for concern.

Diarrhea is not only quite common for cancer patients, it can also be quite dangerous. Diarrhea itself isn’t a disease. Rather, it is a set of symptoms that include loose, watery stools and sometimes abdominal pain associated with several underlying causes, including infection, stress or reaction to medicinal agents. Left untreated, it could lead to intestinal injury, dehydration and loss of important electrolytes.

Cancers that commonly set off diarrhea include a broad set of tumors that produce certain hormones, which in turn stimulate the colon to secrete water. These include neuroendocrine tumors that typically originate from the gastrointestinal tract, but in rare cases diarrhea can be produced by other types of cancer. Some types of chemotherapy often cause diarrhea, especially certain drug regimens, such as those containing fluoropyrimidines (5-FU or Xeloda [capecitabine]) or Camptosar (irinotecan). Radiation to the abdomen, lumbar area, para-aortic lymph nodes or pelvis, and surgeries involving the gastrointestinal system also often cause diarrhea. Antibiotics can also alter the composition of normal bacteria in the gut, leading to infections that can cause cramping and diarrhea. Patients who’ve had surgeries that lower the production of gastric and pancreatic enzymes that digest food can experience chronic bacteria, which may cause diarrhea.

Through its Common Terminology Criteria for Adverse Events, the National Cancer Institute ranks diarrhea severity by a toxicity scale, from relatively moderate (grade 1) to life-threatening or disabling (grade 4). Grade 1 typically involves a few extra stools a day, loose and unformed. Troublesome, yes, and certainly inconvenient, but grade 4 diarrhea—with more than 10 stools a day, blood in the stool and painful cramps—can require hospitalization or even intensive care.

Certain foods and drinks can make diarrhea more likely because they can irritate the digestive system. These include milk, spicy or fatty foods, certain juices and fruits and caffeine. Doctors recommend starting with a BRAT (Bananas, Rice, Apples and white Toast) or ABC (Apples, Bananas and Cereal) diet.

Drinking clear fluids is also essential for replacing fluid lost through bowel movements. NCI recommendations include water, clear broth, some juices (cranberry and grape), decaffeinated tea and oral rehydration drinks such as Pedialyte. There is also evidence that some probiotics can help.

Certain types of cancer treatments are more likely to cause diarrhea than others, so patients and members of their medical teams should discuss the possibility that their health condition or its treatment might result in diarrhea.

For cancer patients, diarrhea is sometimes severe enough to necessitate delaying or even discontinuing treatment, and that can have serious consequences. It is important that patients call their physicians at the earliest signs of diarrhea, especially when they are taking the diarrhea-causing oral chemotherapy Xeloda, since instructions to stop or reduce treatment may be given. When dietary changes are not sufficient to manage diarrhea, over-the-counter and prescription medications may help. These should be discussed with a medical team, but may include over-thecounter products such as Imodium (loperamide) or bismuth subsalicylate (active ingredient in Pepto- Bismol and Kaopectate); or prescription drugs such as Lomotil (diphenoxylate-atropine sulfate) or even codeine and other opioids. For some chemotherapy regimens, preventive measures are prescribed even before diarrhea develops. Patients might sometimes need to be admitted to the hospital if there is dehydration or signs of significant bowel injury and inflammation (colitis).

Articles in this issue

From Our Archives: Imaging
Supplements During Cancer: Help or Hype?
Unlocking the Mystery of Cancer Stem Cells
Advocates Make Cancer Their Mission
Choosing an Imaging Test
Do You Need a Cancer Coach?
Coordinating Care After Cancer
How to Manage Family Dynamics During Cancer
Another State Gets Chemo Parity
Ford Led Discussion on Breast Cancer
Breast Cancer Drug Scores Win in Prevention
Critical Care: A New Nurse Faces Death, Life, and Everything in Between
A Survivorship Resource Map
Q & A: Patients Want Coordinated Care
San Antonio Breast Cancer Symposium

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Content
Advertisement
Image of hand.
June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Jeanine Pronio
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

Alex Biese
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.
June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

Alex Biese
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.
New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.
May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com
May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Alex Biese
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.
May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.
A powerful new ally is emerging in cancer care: artificial intelligence.
Related Content
Advertisement
Image of hand.
June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Jeanine Pronio
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

Alex Biese
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.
June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

Alex Biese
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.
New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.
May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com
May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Alex Biese
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.
May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.
A powerful new ally is emerging in cancer care: artificial intelligence.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.